CF PharmTech Company Description

CF PharmTech, Inc. engages in research and development, production, and sale of respiratory drugs in the field of respiratory diseases in China.

It offers Shufeimin, an azelastine hydrochloride and fluticasone propionate nasal spray; ChangQi, a budesonide inhalation suspension solution; ChangShu, a salbutamol sulfate inhalation solution; and piezoelectric mesh nebulizer, electric nasal cleaner, BFS hypertonic and physiological seawater nasal cleansing fluid products under the ChangShu name.

The company also develops products for the treatment of respiratory diseases, including allergic rhinitis, asthma, chronic obstructive pulmonary, respiratory infection, pulmonary fibrosis, pulmonary hypertension, and other respiratory diseases.

In addition, it develops therapeutic products for respiratory and other diseases, such as inhalation spray and aerosol, dry powder inhaler, nebulization, nasal spray products, as well as liposomes.

Further, the company provides CDMO/CMO technical services. CF PharmTech, Inc. was formerly known as Suzhou CF PharmTech Co., Ltd. CF PharmTech, Inc. was founded in 2007 and is based in Suzhou, China.

CF PharmTech, Inc.

Country	China
Founded	2007
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	574
CEO	Liang Wenqing

Contact Details

Address: No. 16, Hucundang Road Suzhou, 215143 China
Phone	86 512 8686 7555
Website	cfpharmtech.com

Stock Details

Ticker Symbol	2652
Exchange	Hong Kong Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
SIC Code	2834

Key Executives

Name	Position
Dr. Liang Wenqing	Co-Founder, Executive Chairperson and Chief Executive Officer
Dr. Li Li Bovet Ph.D.	Co-Founder, Executive Director and Chief Scientific Officer
Dr. Li Qi	Chief Operating Officer and Executive Director
Zhu Yuyu	Deputy GM, Joint Secretary of the Board and Executive Director
Wei Wei	Head of Finance
Cheuk Ting Chu A.C.S.	Joint Company Secretary